Skip to main content
. 2023 Sep 27;10(6):1597–1607. doi: 10.1007/s40744-023-00598-2

Table 3.

Factors associated with low HCQ and DHCQ concentrations

Variables OR 95% CI P value
HCQ
 Gender (female) 0.23 0.07–0.75 0.015
 Age 0.96 0.94–0.98  < 0.001
 Weight 1.04 1.01–1.06 0.013
 Duration 0.92 0.89–0.95  < 0.001
 SLEDAI 1.41 1.19–1.67  < 0.001
 Platelet 0.99 0.99–1.00  < 0.001
 RBC 1.15 0.71 -1.84 0.575
 Complement C3 0.56 0.11–2.74 0.472
 Complement C4 0.07 0.00–9.55 0.287
 IgG 1.07 1.01–1.12 0.014
DHCQ
 Gender (female) 0.20 0.06–0.64 0.006
 Duration 0.95 0.92–0.97  < 0.001
 SLEDAI 1.27 1.07–1.51 0.007
 Platelet 0.99 0.99–1.00  < 0.001
 ALT 1.01 1.00–1.03 0.146
 Albumin 1.05 0.98–1.12 0.187
 BUN 1.01 0.89–1.15 0.857
 CR 0.99 0.99–1.00 0.158
 eGFR 1.00 0.99–1.00 0.543
 CRP 0.98 0.95–1.00 0.072
 Complement C4 0.04 0.00–2.35 0.122
 IgG 1.02 0.97–1.08 0.418

Significant P values are in bold

OR odds ratio, CI confidence interval, HCQ hydroxychloroquine, DHCQ desethylhydroxychloroquine, Duration duration of HCQ use, SLEDAI systemic lupus erythematosus disease activity index, RBC red blood cell, IgG immunoglobulin G, ALT alanine transaminase, BUN blood urea nitrogen, CR creatinine, eGFR estimated glomerular filtration rate, CRP C-reactive protein